Graft watchdog probes two former officials of ChemChina


FILE PHOTO: The company logo of China National Chemical Corp, or ChemChina, is seen at its headquarters in Beijing, China February 3, 2017. REUTERS/Thomas Peter/File Photo

BEIJING: China’s anti-graft watchdog says it is investigating the former chairman of China state-owned giant National Chemical Corp (ChemChina), for violations of discipline and law, along with another former company official.

The investigations come after Swiss seeds and pesticides group Syngenta withdrew in March its bid for a long-delayed US$9bil initial public offerings (IPO) in Shanghai, which would have been China’s largest, and one of the world’s biggest, flotations this year.

Ren Jianxin, who retired from the firm in June 2018, was suspected of “serious violations of discipline and law”, the Central Commission for Discipline Inspection (CCDI) said in a statement on its website last Saturday.

Dubbed an industrialist turned dealmaker, Ren, 66, served as ChemChina’s chairman and party secretary from December 2014 to 2018, and was the official behind ChemChina’s US$43bil bid to buy Syngenta in 2017.

The graft watchdog added that Yang Xingqiang, a former general manager of ChemChina, was also being investigated.

Yang, 57, who was general manager of ChemChina in December 2014, had worked with Ren as his assistant. In May 2021, he took up the same role at China National Salt Industry Group before stepping down in August 2022.

The watchdog gave no further details.

Chinese authorities had nudged Syngenta to withdraw its IPO application on concerns about the impact a sizeable new offering would have on a volatile market, Reuters reported last month.

The watchdog doubled down this year on a pledge to relentlessly carry out President Xi Jinping’s orders to catch corrupt and disloyal officials, amid an investigation into accusations of graft surrounding military procurement. — Reuters

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
ChemChina , Graft , China

Next In Business News

SNS Network scores record RM1.22bil contract for the supply of servers
CapitaLand Malaysia records higher net profit of RM44mil in 2Q
Wall St futures rise as US, Iran pause hostilities
OCBC Malaysia, CGC launch RM1.3bil guarantee facility to boost SME financing
Malaysia must build future-ready workforce to capitalise on Asia's economic rise
FBM KLCI mirrors upbeat regional performance
Bursa Malaysia to suspend trading in BHIC Securities on Aug 7
MyCEB secures 416 business events for 2026-2030 with RM3.98bil estimated economic impact
South Korea's Naver jumps 10% on Nvidia's US$1bil investment plan
AI to drive Asean+3 growth, 2026 forecast revised higher to 4.1% - AMRO

Others Also Read